Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Lymphoma

Free Subscription Articles published in Radiother Oncol Retrieve available abstracts of 12 articles: HTML format

Single Articles

June 2026
1. BURLILE JF, Harmsen WS, Suddendorf SD, Frechette KM, et al
   Optimizing low dose radiotherapy for indolent lymphomas: comparing 8 Gy in 2 fractions to 4 Gy in 2 fractions.
   Radiother Oncol. 2026;219:111515.
   PubMed     Abstract available
   
   
   April 2026
2. LEVIS M, Solidoro P, Giglioli FR, Gallio E, et al
   Continuous positive airway pressure as an alternative to deep-inspiration breath holding for mediastinal lymphoma radiotherapy.
   Radiother Oncol. 2026;220:111539.
   PubMed     Abstract available
   
   
   February 2026
3. ALI E, Simontacchi G, Levis M, Iori F, et al
   Low-Dose Radiotherapy for Primary Cutaneous Indolent B-Cell Lymphomas: a Multicenter Retrospective Study.
   Radiother Oncol. 2026;215:111327.
   PubMed     Abstract available
   
   
   
4. HIGGINS MJ, Johnstone P, Prince HM, Lade S, et al
   Radiotherapy dose-response of mycosis fungoides with large cell transformation.
   Radiother Oncol. 2026;215:111292.
   PubMed     Abstract available
   
   
   January 2026
5. JOHNSTONE P, Bressel M, Seymour JF, Juneja S, et al
   Secondary outcomes of the TROG 99.03 randomized trial of systemic therapy after involved-field radiotherapy in early-stage follicular lymphoma, including toxicity, relapse and second malignancy data.
   Radiother Oncol. 2026;217:111388.
   PubMed     Abstract available
   
   
   
6. ATTILI A, Algranati C, Cianchetti M, Giacomelli I, et al
   A dedicated MKM-based radiobiological model for secondary cancer estimation in charged particle radiotherapy: An application in lymphomas and breast proton therapy.
   Radiother Oncol. 2026;214:111229.
   PubMed     Abstract available
   
   
   November 2025
7. LAM EK, Luk MY, Yuen KK, Cheung BM, et al
   Bridging radiotherapy for chimeric antigen receptor T cells therapy in non-Hodgkin lymphoma: Systematic review and meta-analysis.
   Radiother Oncol. 2025;214:111258.
   PubMed     Abstract available
   
   
   July 2025
8. BOERSMA LJ, Hessels A, Roberti S, Seravall E, et al
   Selection of patients for proton therapy to reduce risk of second primary lung and breast cancer.
   Radiother Oncol. 2025 Jul 4:110998. doi: 10.1016/j.radonc.2025.110998.
   PubMed     Abstract available
   
   
   June 2025
9. HEIDER S, Allwohn L, Ruhle A, Ehret F, et al
   Comparison of survival and progression after focal- or whole brain radiotherapy in patients with primary CNS lymphoma - Results from a large multicenter analysis of the German Society of Radiation Oncology's Neuro-Radio-Oncology Working Group (DEGRO A
   Radiother Oncol. 2025 Jun 7:110984. doi: 10.1016/j.radonc.2025.110984.
   PubMed     Abstract available
   
   
   May 2025
10. DEDECKOVA K, Andrlik M, Mocikova H, Kaliska L, et al
    Proton beam therapy for mediastinal Hodgkin lymphoma: A prospective study of clinical efficacy and safety.
    Radiother Oncol. 2025 May 10:110931. doi: 10.1016/j.radonc.2025.110931.
    PubMed     Abstract available
    
    
    September 2023
11. WANG X, Liu X, Zhong QZ, Wu T, et al
    Decreased lymphoma-related deaths and improved long-term relative survival with radiotherapy for early-stage diffuse large B-cell lymphoma in the rituximab era.
    Radiother Oncol. 2023 Sep 5:109902. doi: 10.1016/j.radonc.2023.109902.
    PubMed     Abstract available
    
    
    August 2023
12. HOFFMANN L, Ehmsen ML, Hansen J, Hansen R, et al
    Repeated deep-inspiration breath-hold CT scans at planning underestimate the actual motion between breath-holds at treatment for lung cancer and lymphoma patients.
    Radiother Oncol. 2023 Aug 31:109887. doi: 10.1016/j.radonc.2023.109887.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum